clonidine has been researched along with Pernicious Vomiting of Pregnancy in 2 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Excerpt | Relevance | Reference |
---|---|---|
"To study the efficacy of transdermal clonidine in the treatment of severe refractory hyperemesis gravidarum (HG), the most severe illness of pregnancy." | 5.19 | Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI. ( Arrotta, M; Cicogna, L; Donvito, V; Maina, A; Mischinelli, M; Rivolo, S; Todros, T, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maina, A | 1 |
Arrotta, M | 1 |
Cicogna, L | 1 |
Donvito, V | 1 |
Mischinelli, M | 1 |
Todros, T | 1 |
Rivolo, S | 1 |
Stephansson, O | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The CLONEMESI Study: a Randomized Placebo-controlled Study With Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum.[NCT01559012] | Phase 3 | 13 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"The patients were randomly treated with and without TD clonidine (5mg patch) for 2 consecutive periods of 5 days , other antiemetic drugs (promethazine, prochlorperazine, metoclopramide, ondansetron) and anti reflux drugs (ranitidine, omeprazole) being administered on a scheduled or as-needed basis.~All patients received intravenous hydration and supplementation with thiamine, during both periods. The use of steroids was allowed as a rescue medication in case of further worsening of symptoms." (NCT01559012)
Timeframe: participants are followed for the whole duration of hospital stay (10 days) comparing the first period of 5 days with the second period of 5 days
Intervention | daily doses of antiemetics (Mean) |
---|---|
Clonidine | 1.5 |
Placebo | 2.3 |
Diastolic BP was recorded every day during clonidine (5 days) and placebo (5 days) cycle (NCT01559012)
Timeframe: 10 days
Intervention | mmHg (Mean) |
---|---|
Clonidine | 58 |
Placebo | 61 |
Morning urine ketonuria is a simple direct marker of starving associated to nausea and vomiting (NCT01559012)
Timeframe: participants are followed for the whole duration of hospital stay (10 days) comparing the first period of 5 days with the second period of 5 days
Intervention | Proportion of person-days (Mean) |
---|---|
Clonidine | 0.06 |
Placebo | 0.36 |
"The APGAR score is the most common indicator of neonatal status immediately after delivery.~The test is done by a doctor, midwife, or nurse. The health care provider will examine the baby's:~Breathing effort Heart rate Muscle tone Reflexes Skin color Each category is scored with 0, 1, or 2, depending on the observed condition. The APGAR rating is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth." (NCT01559012)
Timeframe: at 1 minute and at 5 minutes after delivery
Intervention | units on a scale (Mean) |
---|---|
APGAR Score at 1' | 9 |
APGAR Score at 5' | 9 |
if the symptoms improve the patient and her doctors may decide to stop parenteral drugs continuing the TD system therapy. (NCT01559012)
Timeframe: participants are followed for the whole duration of hospital stay (10 days) comparing the first period of 5 days with the second period of 5 days
Intervention | Proportion of person-days (Mean) |
---|---|
Clonidine | 0.40 |
Placebo | 0.20 |
the patients were asked to choose between two transdermal systems (active drug versus placebo) as the most effective (NCT01559012)
Timeframe: at 10 days since start of treatment
Intervention | participants (Number) |
---|---|
Clonidine | 9 |
Placebo | 3 |
Birth weight adjusted for gestational age at delivery is a measure of pregnancy outcome after treatment of HG. (NCT01559012)
Timeframe: at delivery
Intervention | grams (Mean) |
---|---|
Mean Birth Weight of 12 Patients | 3312 |
"PUQE in an acronym for Pregnancy Unique Quantification of Emesis, a validated clinical score for assessment of severity of emesis in pregnancy.~It is composed of three items; every item has a score from 1 (best) to 5 (worst).~The sum range varies from 3 (best) to 15 (worst). Participants are followed for the whole duration of hospital stay (10 days) asking them to score their symptoms daily." (NCT01559012)
Timeframe: Mean values of first period of five days are compared with mean values of second period of five days. Change is reported as baseline value - value at day 5 or at day 10.
Intervention | units on a scale (Mean) |
---|---|
Clonidine | 6.3 |
Placebo | 8.5 |
Systolic BP was measured every day during the clonidine treatment (5 days) and placebo (5 days) (NCT01559012)
Timeframe: 10 days
Intervention | mmHg (Mean) |
---|---|
Clonidine | 91 |
Placebo | 97 |
VAS is a Visual Analogic Scale formulated in 5 items. Every item has a score from 0 (best) to 10 (worst). The sum range swings from 0 (best ) to 50 (worst). Participants are followed for the whole duration of hospital stay (10 days) asking them to score their symptoms daily. (NCT01559012)
Timeframe: Mean values of first period of five days are compared with mean values of second period of five days. Change is reported as baseline value - value at day 5 or at day 10.
Intervention | units on a scale (Mean) |
---|---|
Clonidine | 22 |
Placebo | 29 |
1 trial available for clonidine and Pernicious Vomiting of Pregnancy
Article | Year |
---|---|
Transdermal clonidine in the treatment of severe hyperemesis. A pilot randomised control trial: CLONEMESI.
Topics: Administration, Cutaneous; Adult; Antiemetics; Clonidine; Cross-Over Studies; Double-Blind Method; D | 2014 |
1 other study available for clonidine and Pernicious Vomiting of Pregnancy
Article | Year |
---|---|
A novel study on transdermal clonidine treatment of hyperemesis gravidarum.
Topics: Antiemetics; Clonidine; Female; Humans; Hyperemesis Gravidarum; Pregnancy | 2014 |